Navigation Links
BD Announces Executive Appointments of President and Chief Financial Officer
Date:11/5/2008

FRANKLIN LAKES, N.J., Nov. 5 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the appointment of Vincent A. Forlenza as President, effective January 1, 2009, and David V. Elkins as Executive Vice President and Chief Financial Officer, effective December 1, 2008.

Mr. Forlenza will report to Edward J. Ludwig, who will remain as Chairman and Chief Executive Officer. Mr. Elkins will also report to Mr. Ludwig. John R. Considine will remain as Vice Chairman.

As President, Mr. Forlenza will oversee BD's three business segments (BD Medical, BD Diagnostics and BD Biosciences), International and the Quality function. He will continue to be a member of the Office of the CEO, along with Vice Chairman John Considine, Executive Vice Presidents Gary Cohen, John Hanson and William Kozy, and David Elkins, who will join the Office of the CEO.

"Vince has a long track record of success at BD, and he has played a critical role in developing and implementing BD's strategy and vision," said Ed Ludwig. "His new role is representative of his leadership, commitment and dedication to ensuring the ongoing and future success of the Company."

Mr. Forlenza, 55, joined BD in 1980. His BD career has spanned strategic planning, marketing, general management of several business units and executive leadership. His prior roles include service in all three business segments, including service as General Manager, Hypodermic - Europe; President, Becton Dickinson Microbiology Systems; Senior Vice President, Technology, Strategy and Development; and President, BD Biosciences. He was named Executive Vice President in 2006 and was most recently responsible for leading BD Diagnostics.

Mr. Forlenza obtained his bachelor's degree in chemical engineering from Lehigh University and his MBA from Wharton Graduate School, University of Pennsylvania. He serves as chairman of The Valley Hospital Board of Trustees and is a member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University.

Mr. Elkins, 40, will be responsible for executive management and oversight of BD's global financial operations. He joins BD from AstraZeneca, where he has served since 2006 as Vice President, Chief Financial Officer, North America and Global Marketing, a $13 billion business. John Considine will continue to be responsible for Integrated Supply Chain; Information Technology; Environment, Health and Safety; Project Management and Engineering Services; and Security.

"We are very pleased to welcome David as a member of our executive management team in this key role," said Ed Ludwig. "He brings to BD a wealth of deep and diverse experience in global finance and healthcare. We look forward to leveraging his insight and expertise as we continue to implement our strategy of driving revenue growth through innovation, complemented by driving operating effectiveness and productivity."

Among Mr. Elkins' prior roles during his 12-year career with AstraZeneca are service as Chief Financial Officer, U.K.; Senior Finance Director - Gastrointestinal and Respiratory; Assistant Treasurer; Senior Finance Manager - Product Strategy and Business Development; Biotechnology Finance Manager; and Regional Finance Manager - Asia.

Mr. Elkins obtained his B.S. degree in economics from the University of Delaware, his MBA from Drexel University and his M.S. degree in Organizational Dynamics from the University of Pennsylvania. He serves on the Audit Committee of the University of Delaware and the Board of the United Way of Delaware.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BD Announces Results for Fourth Fiscal Quarter and Full Year
2. Office Zone Announces New Line of 'Safer' Paper Shredders
3. XTENT Announces Third Quarter 2008 Financial Results
4. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
5. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
6. Weight Watchers Announces Third Quarter 2008 Results
7. United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results
8. Carriage Services Announces Third Quarter 2008 Results
9. Healthcare Realty Trust Announces Third Quarter Dividend
10. Lloyd I. Miller III Announces Voting Intentions for United American Healthcares Annual Meeting
11. Vericept Announces 100 Customers in Healthcare Industry for Sensitive Data Protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Leading dental clinicians, Drs. Ashlyn ... with the VATECH PaX-i and Anatomage systems. With advanced digital images and modeling capabilities, ... place dental implants precisely and restore oral health for those who are missing ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... Innovation Catalyst program focused on finding product improvements that could reduce the ... their throats when they need help breathing or to provide medication. Sometimes, patient ...
(Date:6/20/2017)... ... 2017 , ... BrightStar Care Centerville/South Dayton, a home care ... Commission, which accredits and certifies nearly 21,000 healthcare organizations and programs in the ... of quality that reflects an organization’s commitment to meeting certain performance standards. , ...
(Date:6/20/2017)... ... 20, 2017 , ... The law firm of Momkus McCluskey Roberts LLC ... of the DuPage County Bar Association’s Board of Directors. Cassioppi officially took on the ... Drake in Oak Brook. Momkus McCluskey Roberts LLC attorney Stacey A. McCullough was also ...
(Date:6/19/2017)... Chicago, I.L. (PRWEB) , ... June 19, 2017 ... ... DIA’s Annual Meeting, designed to foster the international exchange of actionable insights ... will be discussing its mission to make clinical trial management faster, easier, ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... Kohll,s Pharmacy & Homecare is the first distributor of ... . The Raizer is a simple battery operated mobile ... an almost-standing position within a few minutes. The ... and does not require any extra effort besides a ... can operate it, and lightweight and portable so ...
(Date:6/1/2017)... Nutriceutical Holdings (NH), parent company of Physician ... KD Pharma Group have decided to join forces through ... Group. KD Pharma Group will become the largest shareholder ... entire company. "We believe we have found ... growing the NH companies by providing us with supply ...
(Date:5/30/2017)... Therapix Biosciences Ltd. (Nasdaq: TRPX), a ... development of cannabinoid-based drugs, today announced that the ... three upcoming scientific and investor conferences in June: ... ... Wednesday, June 7 ...
Breaking Medicine Technology: